AT359213B - Verfahren zur herstellung von neuen, in 11- -stellung substituierten steroiden der oestran- -reihe - Google Patents

Verfahren zur herstellung von neuen, in 11- -stellung substituierten steroiden der oestran- -reihe

Info

Publication number
AT359213B
AT359213B AT318475A AT318475A AT359213B AT 359213 B AT359213 B AT 359213B AT 318475 A AT318475 A AT 318475A AT 318475 A AT318475 A AT 318475A AT 359213 B AT359213 B AT 359213B
Authority
AT
Austria
Prior art keywords
production
new steroids
series substituted
oestrane series
oestrane
Prior art date
Application number
AT318475A
Other languages
English (en)
Other versions
ATA318475A (de
Inventor
Den Broek Albertus Joannes Van
Winter Max Salomon De
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ATA318475A publication Critical patent/ATA318475A/de
Application granted granted Critical
Publication of AT359213B publication Critical patent/AT359213B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AT318475A 1974-04-26 1975-04-24 Verfahren zur herstellung von neuen, in 11- -stellung substituierten steroiden der oestran- -reihe AT359213B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7405626A NL7405626A (nl) 1974-04-26 1974-04-26 Nieuwe 11-gesubstitueerde steroiden van de oestraanreeks.

Publications (2)

Publication Number Publication Date
ATA318475A ATA318475A (de) 1980-03-15
AT359213B true AT359213B (de) 1980-10-27

Family

ID=19821231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT318475A AT359213B (de) 1974-04-26 1975-04-24 Verfahren zur herstellung von neuen, in 11- -stellung substituierten steroiden der oestran- -reihe

Country Status (18)

Country Link
US (1) US3972906A (de)
JP (1) JPS50142556A (de)
AT (1) AT359213B (de)
BE (1) BE828447A (de)
CA (1) CA1056370A (de)
CH (1) CH618181A5 (de)
DE (1) DE2518547A1 (de)
DK (1) DK138697B (de)
ES (1) ES436846A1 (de)
FI (1) FI55209C (de)
FR (1) FR2268528B1 (de)
GB (1) GB1502326A (de)
HU (1) HU172440B (de)
IE (1) IE41233B1 (de)
NL (1) NL7405626A (de)
PH (1) PH12178A (de)
SE (1) SE416054B (de)
ZA (1) ZA752358B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
FR2613937B1 (fr) * 1987-04-17 1989-07-21 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides utiles pour la therapie ciblee ou l'imagerie medicale notamment du cancer
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
FR2637803B1 (fr) * 1988-10-19 1993-07-09 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides estrogenes et progestagenes, application et produits intermediaires de synthese
US9315539B2 (en) * 2002-10-01 2016-04-19 Yale University 11 beta-short chain substituted estradiol analogs and their use in the treatment of menopausal symptoms and estrogen sensitive cancer
EP2053055A1 (de) * 2007-10-24 2009-04-29 Bayer Schering Pharma Aktiengesellschaft 11.beta.-Fluoro-3-acetoxyestra-3,5-dien-17-on und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
DE2518547A1 (de) 1975-11-13
FR2268528B1 (de) 1980-01-25
SE416054B (sv) 1980-11-24
FI751214A (de) 1975-10-27
ATA318475A (de) 1980-03-15
SE7504809L (sv) 1975-10-27
GB1502326A (en) 1978-03-01
FI55209B (fi) 1979-02-28
IE41233L (en) 1975-10-26
FI55209C (fi) 1979-06-11
ES436846A1 (es) 1976-12-01
CH618181A5 (de) 1980-07-15
CA1056370A (en) 1979-06-12
PH12178A (en) 1978-11-21
NL7405626A (nl) 1975-10-28
IE41233B1 (en) 1979-11-21
DK181475A (de) 1975-10-27
US3972906A (en) 1976-08-03
ZA752358B (en) 1976-03-31
DK138697B (da) 1978-10-16
FR2268528A1 (de) 1975-11-21
HU172440B (hu) 1978-09-28
JPS50142556A (de) 1975-11-17
AU8024875A (en) 1976-10-21
BE828447A (fr) 1975-10-27
DK138697C (de) 1979-04-30

Similar Documents

Publication Publication Date Title
AT348693B (de) Verfahren zur herstellung von neuen decapeptidamidderivaten
AT344890B (de) Verfahren zur herstellung von neuen 6-thiatetracyclinen
AT344333B (de) Verfahren zur herstellung von neuen 8-thiomethylergolinen
AT336589B (de) Verfahren zur herstellung von neuen biphenylderivaten
AT345998B (de) Verfahren zur herstellung von neuen 18-methyl- 19-nor-20-keto-pregnanen
AT350064B (de) Verfahren zur herstellung von neuen thienothiazinderivaten
AT350529B (de) Verfahren zur herstellung von neuen acylaminophenylalkylaminen
AT345815B (de) Verfahren zur herstellung von neuen thiadiazolylimidazolidinonderivaten
AT343675B (de) Verfahren zur herstellung von neuen biguaniden
ATA428075A (de) Verfahren zur herstellung von neuen 1-aethyl-3a-metasubstituiertes-phenyl-decahydroisochinolinen
AT351183B (de) Verfahren zur herstellung von neuen prosta- glandinen
AT359213B (de) Verfahren zur herstellung von neuen, in 11- -stellung substituierten steroiden der oestran- -reihe
AT351182B (de) Verfahren zur herstellung von neuen 9-thia-, 9-oxothia- und 9-dioxothia- 11,12-secoprosta- glandinen
AT337672B (de) Verfahren zur herstellung von neuen abietamidderivaten
AT342590B (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen
AT337897B (de) Verfahren zur herstellung von neuen acylderivaten
AT341539B (de) Verfahren zur herstellung von neuen 3-amino-2beta-thiohydrazoazetidinonen
AT342046B (de) Verfahren zur herstellung von neuen n-benzylaminooxazolinen
AT349160B (de) Verfahren zur herstellung von neuen bufatrienolidrhamnosidaethern
AT348697B (de) Verfahren zur herstellung von neuen d- homosteroiden
AT341489B (de) Verfahren zur herstellung von neuen acetoximderivaten
AT345485B (de) Verfahren zur herstellung von neuen kortikoiden
AT355034B (de) Verfahren zur herstellung von neuen 3- acylamino-2-azetidinonderivaten
ATA548975A (de) Verfahren zur herstellung von neuen beta-acyloxycrotonsaureamid-n-sulfohalogeniden
AT331423B (de) Verfahren zur herstellung von neuen desglucohellebrin-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee